FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1444601816> ?p ?o ?g. }

• W1444601816 endingPage "1198" @default.
• W1444601816 startingPage "1192" @default.
• W1444601816 abstract "Pemetrexed plus carboplatin therapy is widely administered to patients with non-squamous non-small cell lung cancer. Although severe neutropenia is often observed during this combination therapy, its predictive factors are unknown. Therefore, we investigated the predictive factors for severe neutropenia in 77 patients treated with this combination therapy at the Department of Respiratory Medicine, Kyushu University Hospital, between September 2009 and September 2013. All data were retrospectively collected from the electronic medical record system, and univariate and multivariate logistic regression analyses were performed to identify risk factors for grade 3 or 4 neutropenia. Among the 77 patients, 34 (44%) developed grade 3 or 4 neutropenia. Multivariate analysis revealed that lower baseline hemoglobin values (odds ratio [OR], 1.97 per 1 g/dL decrease; 95% confidence interval [CI], 1.39-2.99, p<0.01) and lower baseline neutrophil counts (OR, 1.71 per 1000/mm(3) decrease; 95% CI, 1.14-2.71, p=0.01) were significantly associated with grade 3 or 4 neutropenia. During 4 courses of pemetrexed plus carboplatin therapy, the incidence of grade 3 or 4 neutropenia in patients with baseline hemoglobin values of <11.6 g/dL was significantly higher than that in patients with values of ≥11.6 g/dL [84% (16/19) vs. 31% (18/58), p<0.001]. In conclusion, patients with lower baseline neutrophil counts or lower baseline hemoglobin values, especially those with baseline hemoglobin values of <11.6 g/dL, should be monitored more carefully during pemetrexed plus carboplatin therapy." @default.
• W1444601816 created "2016-06-24" @default.
• W1444601816 creator A5003016795 @default.
• W1444601816 creator A5004410085 @default.
• W1444601816 creator A5005499463 @default.
• W1444601816 creator A5011258855 @default.
• W1444601816 creator A5019252503 @default.
• W1444601816 creator A5033145432 @default.
• W1444601816 creator A5035882975 @default.
• W1444601816 creator A5039054605 @default.
• W1444601816 creator A5044370173 @default.
• W1444601816 creator A5067065168 @default.
• W1444601816 creator A5079275805 @default.
• W1444601816 creator A5083687117 @default.
• W1444601816 creator A5088855093 @default.
• W1444601816 creator A5091093961 @default.
• W1444601816 date "2015-01-01" @default.
• W1444601816 modified "2023-09-23" @default.
• W1444601816 title "Risk Factors for Predicting Severe Neutropenia Induced by Pemetrexed Plus Carboplatin Therapy in Patients with Advanced Non-small Cell Lung Cancer" @default.
• W1444601816 cites W1907795058 @default.
• W1444601816 cites W1965581368 @default.
• W1444601816 cites W1967604344 @default.
• W1444601816 cites W2002574045 @default.
• W1444601816 cites W2006995477 @default.
• W1444601816 cites W2014672695 @default.
• W1444601816 cites W2018331131 @default.
• W1444601816 cites W2044201404 @default.
• W1444601816 cites W2055728122 @default.
• W1444601816 cites W2073875673 @default.
• W1444601816 cites W2093916341 @default.
• W1444601816 cites W2099214237 @default.
• W1444601816 cites W2099725888 @default.
• W1444601816 cites W2103282042 @default.
• W1444601816 cites W2106404091 @default.
• W1444601816 cites W2106664438 @default.
• W1444601816 cites W2106787323 @default.
• W1444601816 cites W2113577258 @default.
• W1444601816 cites W2126310082 @default.
• W1444601816 cites W2131596319 @default.
• W1444601816 cites W2136271461 @default.
• W1444601816 cites W2148367564 @default.
• W1444601816 cites W2149804121 @default.
• W1444601816 cites W2161965680 @default.
• W1444601816 doi "https://doi.org/10.1248/bpb.b15-00162" @default.
• W1444601816 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26235582" @default.
• W1444601816 hasPublicationYear "2015" @default.
• W1444601816 type Work @default.
• W1444601816 sameAs 1444601816 @default.
• W1444601816 citedByCount "15" @default.
• W1444601816 countsByYear W14446018162016 @default.
• W1444601816 countsByYear W14446018162017 @default.
• W1444601816 countsByYear W14446018162018 @default.
• W1444601816 countsByYear W14446018162019 @default.
• W1444601816 countsByYear W14446018162020 @default.
• W1444601816 countsByYear W14446018162022 @default.
• W1444601816 crossrefType "journal-article" @default.
• W1444601816 hasAuthorship W1444601816A5003016795 @default.
• W1444601816 hasAuthorship W1444601816A5004410085 @default.
• W1444601816 hasAuthorship W1444601816A5005499463 @default.
• W1444601816 hasAuthorship W1444601816A5011258855 @default.
• W1444601816 hasAuthorship W1444601816A5019252503 @default.
• W1444601816 hasAuthorship W1444601816A5033145432 @default.
• W1444601816 hasAuthorship W1444601816A5035882975 @default.
• W1444601816 hasAuthorship W1444601816A5039054605 @default.
• W1444601816 hasAuthorship W1444601816A5044370173 @default.
• W1444601816 hasAuthorship W1444601816A5067065168 @default.
• W1444601816 hasAuthorship W1444601816A5079275805 @default.
• W1444601816 hasAuthorship W1444601816A5083687117 @default.
• W1444601816 hasAuthorship W1444601816A5088855093 @default.
• W1444601816 hasAuthorship W1444601816A5091093961 @default.
• W1444601816 hasBestOaLocation W14446018161 @default.
• W1444601816 hasConcept C126322002 @default.
• W1444601816 hasConcept C141071460 @default.
• W1444601816 hasConcept C144301174 @default.
• W1444601816 hasConcept C156957248 @default.
• W1444601816 hasConcept C2776256026 @default.
• W1444601816 hasConcept C2776694085 @default.
• W1444601816 hasConcept C2777063308 @default.
• W1444601816 hasConcept C2777240266 @default.
• W1444601816 hasConcept C2778239845 @default.
• W1444601816 hasConcept C2781451048 @default.
• W1444601816 hasConcept C38180746 @default.
• W1444601816 hasConcept C71924100 @default.
• W1444601816 hasConcept C90924648 @default.
• W1444601816 hasConceptScore W1444601816C126322002 @default.
• W1444601816 hasConceptScore W1444601816C141071460 @default.
• W1444601816 hasConceptScore W1444601816C144301174 @default.
• W1444601816 hasConceptScore W1444601816C156957248 @default.
• W1444601816 hasConceptScore W1444601816C2776256026 @default.
• W1444601816 hasConceptScore W1444601816C2776694085 @default.
• W1444601816 hasConceptScore W1444601816C2777063308 @default.
• W1444601816 hasConceptScore W1444601816C2777240266 @default.
• W1444601816 hasConceptScore W1444601816C2778239845 @default.
• W1444601816 hasConceptScore W1444601816C2781451048 @default.
• W1444601816 hasConceptScore W1444601816C38180746 @default.
• W1444601816 hasConceptScore W1444601816C71924100 @default.
• W1444601816 hasConceptScore W1444601816C90924648 @default.
• W1444601816 hasIssue "8" @default.

• next